Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antagonists or altruists: do viral mutants modulate T-cell responses?

M P Davenport1

  • 1Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, UK.

Immunology Today
|September 1, 1995
PubMed
Summary

Altered peptide ligands (APLs) can modulate T-cell responses. A proposed model suggests viral variants with antagonistic mutations downregulate host immunity, but this study highlights issues with that simple view.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post transplant CMV-specific T-cell immune reconstitution in the absence of global T-cell immunity is associated with a high risk of subsequent virus reactivation.

Bone marrow transplantation·2014
Same author

Channel catfish (Ictalurus punctatus) muscle protein isolate performance processed under different acid and alkali pH values.

Journal of food science·2011
Same author

Reducing chimera formation during PCR amplification to ensure accurate genotyping.

Gene·2010
Same author

The null oncogene hypothesis and protection from cancer.

Journal of medical genetics·2002
Same author

Rapid disease progression and the rate of spread of the HIV epidemic.

AIDS (London, England)·2001
Same author

Benefits of memory.

Nature immunology·2001

Area of Science:

  • Immunology
  • Virology
  • Computational Biology

Background:

  • Altered peptide ligands (APLs) demonstrate potential for modulating T-cell responses in vitro.
  • A recent hypothesis proposed that viral variants with mutations in cytotoxic T lymphocyte (CTL) epitopes may engage in mutual antagonism to suppress host immune responses.

Purpose of the Study:

  • To critically evaluate the proposed model of viral variant antagonism.
  • To explore the complexities of viral competition in host-viral interactions.

Main Methods:

  • Theoretical analysis of proposed models.
  • Review of existing literature on viral evolution and immune evasion.

Main Results:

  • Identified inherent limitations and potential flaws in the simple model of viral variant antagonism.

Related Experiment Videos

  • Highlighted the need for a more nuanced understanding of viral competition.

    • Conclusions:

    • The proposed model of viral variants directly downregulating host immunity through CTL epitope antagonism requires closer scrutiny.
    • Further investigation into the multifaceted effects of viral competition on host-viral dynamics is warranted.